4DMedical partners with Asthma Australia
Posted 1 September 2021 Asthma Australia and BioMelbourne Network member 4DMedical have announced a partnership recognising a mutual commitment to promote awareness and improve diagnostic technology for 2.7 million people living with asthma. Asthma is a life-long respiratory…
Partnership to develop new drugs for childhood solid tumours
Posted 29 August 2021 BioMelbourne Network member Oncology One has announced a new partnership with Children’s Cancer Institute to develop new drugs for the treatment of childhood solid tumours. The partnership is focused on the development of novel…
ANDHealth Receives $19.75M From Medical Research Future Fund
Posted 20 August 2021 ANDHealth, Australia’s leading digital health commercialisation organisation, has today announced it has been successful in securing $19.75M in funding received from the Australian Federal Government under the Medical Research Future Fund (MRFF) Early Stage…
Imagion Biosystems enters agreement for treating breast cancer
Posted 16 August 2021 BioMelbourne member Imagion Biosystems Limited, a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to announce it has entered into a Joint Development Agreement with Global Cancer Technology (GCT),…
4DMedical signs commercial contract with pharmaceutical company
Posted 9 August 2021 Respiratory imaging disruptor and BioMelbourne Network member 4DMedical today announced the signing of a commercial contract with Novartis. Under the terms of the agreement, XV Ventilation Reports will be provided to Novartis on a…
BioCurate and Monash accelerate research into treatments for breast cancer
Posted: 2 August 2021 The first award under BioCurate’s new “Proof of Concept” fund has been granted to the Monash Biomedicine Discovery Institute (BDI). This award will support the key research needed to determine the effectiveness of targeting…
CTxONE Launches New Name, New Brand > Oncology One
Posted: 27 July 2021 Australian biotech company and BioMelbourne member, CTxONE, has announced it has re-branded to ‘Oncology One’ – a move that will support its goal to raise and deploy meaningful capital to progress small molecule cancer…
Johnson & Johnson Innovation announces extension of partnering office at Monash University
Date Posted – 15 July 2021 Victorian State Government extends financing of JJIPO@Monash for an additional two years Extension will further boost Victorian hub for researchers and early-stage companies to connect with industry experts and deliver novel healthcare…
Investors buoyed by positive data for Immutep’s immunotherapy
Date Posted – 7 June 2021 Small cap immunotherapy biotech Immutep is a step closer to commercialising its leading drug candidate, “efti”, after releasing promising data showing the effectiveness of the drug in treating various types of lung,…
Falling Walls Lab is coming to Victoria!
Date Posted: 1 June 2021 Closing date: 28 June 2021 Falling Walls Lab asks one question Which are the next walls to fall? veski and Deakin University are hosting the Falling Walls Lab Victoria in 2021 – a…
Intellectual Property and Marketing Campaigns
Date Posted – 1 June 2021 by Katarina Klaric, Principal, Stephens Lawyers & Consultants. Marketing and advertising campaigns can play a significant role in building brand awareness, increasing sales and revenue and enhancing the value of company or…
Advertising Compliance: Therapeutic Goods Act and Australian Consumer Law
Date Posted – 1 June 2021 by Katarina Klaric, Principal, Stephens Lawyers & Consultants Knowing the advertising laws that apply to the marketing and advertising of a particular product or services is critical to avoid breaches resulting…
